Dark

Check out our API

ENFN
Enfusion, Inc.
stock NYSE

Inactive

Apr 17, 2025

10.76USD-0.370%(-0.04)2,461,878

Pre-market

0.00USD-100.000%(-10.80)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 6, 2022

08:24AM EST Enfusion Elevates Iris Xinwei Wang to Chief Strategy Officer and Lotte Tonsberg to Head of EMEA Sales and Executive Director, EMEA Business Wire

Jan 5, 2022

09:40AM EST Built In Honors Enfusion in Its Esteemed 2022 Best Places to Work Awards Business Wire

Dec 22, 2021

09:07AM EST Enfusion, Coinbase Report Established Connection Between Their Systems To Enable Financial Institutions, Investment Managers To Trade Crypto At Coinbase Benzinga

09:00AM EST Enfusion and Coinbase to Bring Seamless Digital Asset Connectivity to Institutions Business Wire

Dec 17, 2021

10:00AM EST Enfusion Changes the Game for Portfolio Managers and Traders with Full Portfolio Transparency and Control on Mobile Business Wire

Dec 7, 2021

01:00PM EST Enfusion Welcomes New Chief People Officer, Expands Board of Directors Business Wire

Dec 3, 2021

12:00PM EST Enfusion shares were trading higher after the company reported better-than-expected Q3 sales results. The company also issued Q4 and FY21 sales guidance above analyst estimates. Benzinga

08:28AM EST Morgan Stanley Maintains Equal-Weight on Enfusion, Lowers Price Target to $22 Benzinga

07:19AM EST Credit Suisse Maintains Neutral on Enfusion, Lowers Price Target to $25 Benzinga

Dec 2, 2021

04:31PM EST Enfusion Sees Q4 2021 Revenue $30M-$30.5M Vs $28.97M Est; Sees FY21 Revenue $109.8M-$110.3M Vs $106.56M Est Benzinga

04:29PM EST Enfusion Q3 Sales $29.00M Beat $26.72M Estimate Benzinga

04:26PM EST Enfusion Announces Third Quarter 2021 Results Business Wire

04:31AM EST Earnings Scheduled For December 2, 2021 Benzinga

Nov 16, 2021

10:50AM EST William Blair Initiates Coverage On Enfusion with Outperform Rating Benzinga

Nov 15, 2021

11:20AM EST Benzinga's Top Ratings Upgrades, Downgrades For November 15, 2021 Benzinga

10:56AM EST Stifel Initiates Coverage On Enfusion with Buy Rating, Announces Price Target of $27 Benzinga

10:53AM EST B of A Securities Initiates Coverage On Enfusion with Buy Rating, Announces Price Target of $30 Benzinga

10:53AM EST Morgan Stanley Initiates Coverage On Enfusion with Equal-Weight Rating, Announces Price Target of $24 Benzinga

10:49AM EST Credit Suisse Initiates Coverage On Enfusion with Neutral Rating, Announces Price Target of $26 Benzinga

10:46AM EST Goldman Sachs Initiates Coverage On Enfusion with Neutral Rating, Announces Price Target of $26 Benzinga

10:44AM EST Piper Sandler Initiates Coverage On Enfusion with Overweight Rating, Announces Price Target of $26 Benzinga

Oct 30, 2021

01:30PM EDT Last Week's Notable Insider Buys: Beacon Roofing Supply, Enfusion, Nerdy And More Benzinga

Oct 25, 2021

06:39PM EDT Enfusion Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares Business Wire

Oct 21, 2021

12:55PM EDT EXCLUSIVE: Enfusion CEO, Thomas Kim Says Co Largest Segment Is The Alternative Investment Management Including Private Equity, Family Offices And Institutions, Says Co's International Exposure Continues To Expand Internationally Benzinga

12:53PM EDT EXCLUSIVE: Enfusion CEO, Thomas Kim Says Co Has 635 Global Clients, Says Co Added 106 New Clients In 2021 Benzinga

12:49PM EDT EXCLUSIVE: Enfusion CEO, Thomas Kim Says Co Has Been Profitable Says Co Is Organically Hyper Growth Benzinga

12:47PM EDT EXCLUSIVE: Enfusion CEO, Thomas Kim Now Interviewing On Benzinga's Power Hour Show Benzinga

12:12PM EDT EXCLUSIVE: Enfusion CEO, Thomas Kim To Appear On Benzinga's Power Hour Show At 12:45 p.m. ET Benzinga

12:12PM EDT Enfusion Shares Open For Trade At $20; IPO Priced At $17/Share Benzinga

12:12PM EDT Several IPOs Expected For Thursday, Including: Portillo's (PTLO), Enfusion (ENFN), Runway Growth Finance (RWAY), Ventyx Biosciences (VTYX), The Vita Coco Co. (COCO) Benzinga

12:12PM EDT Benzinga Pro's Top 5 Stocks To Watch For Thursday, Oct. 21, 2021: AMD, F, PINS, HX, ENFN Benzinga

12:12PM EDT Enfusion Late Wednesday Priced ~18.5M Share IPO (~15.3M By The Co., ~3.4M By Existing Shareholders) At $17/Share; Expected To Begin Trade Thursday Benzinga

Oct 20, 2021

09:26PM EDT Enfusion Announces Pricing Of IPO At $17.00/shr RTTNews

09:08PM EDT Enfusion Announces Pricing of Initial Public Offering Business Wire

Share